CLDN1 and neoplasm: (100) in a clinical study involving 81 lung adenocarcinoma patients, demonstrated that CLDN1 is transcriptionally regulated by the c-Fos signaling pathway, and that its upregulation significantly inhibits tumor invasion and metastasis.